Caplin Point Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 to consider and approve the unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2025.
The above information is a part of company’s filings submitted to BSE.